Ionis Pharmaceuticals, Inc. (IONS) Net margin 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) net profit margin by fiscal year — reported net income divided by reported revenue.
-40.4%FY2025 · since FY2016: -16.2% → -40.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -40.4% | +24.0 pp |
| FY2024 | -64.4% | -17.9 pp |
| FY2023 | -46.5% | -0.6 pp |
| FY2022 | -45.9% | -42.4 pp |
| FY2021 | -3.5% | +57.4 pp |
| FY2020 | -60.9% | -85.7 pp |
| FY2019 | 24.8% | -20.9 pp |
| FY2018 | 45.6% | +45.6 pp |
| FY2017 | 0.1% | +16.3 pp |
| FY2016 | -16.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice